Mechanistic link between diesel exhaust particles and respiratory reflexes - 07/03/18
Abstract |
Background |
Diesel exhaust particles (DEPs) are a major component of particulate matter in Europe's largest cities, and epidemiologic evidence links exposure with respiratory symptoms and asthma exacerbations. Respiratory reflexes are responsible for symptoms and are regulated by vagal afferent nerves, which innervate the airway. It is not known how DEP exposure activates airway afferents to elicit symptoms, such as cough and bronchospasm.
Objective |
We sought to identify the mechanisms involved in activation of airway sensory afferents by DEPs.
Methods |
In this study we use in vitro and in vivo electrophysiologic techniques, including a unique model that assesses depolarization (a marker of sensory nerve activation) of human vagus.
Results |
We demonstrate a direct interaction between DEP and airway C-fiber afferents. In anesthetized guinea pigs intratracheal administration of DEPs activated airway C-fibers. The organic extract (DEP-OE) and not the cleaned particles evoked depolarization of guinea pig and human vagus, and this was inhibited by a transient receptor potential ankyrin-1 antagonist and the antioxidant N-acetyl cysteine. Polycyclic aromatic hydrocarbons, major constituents of DEPs, were implicated in this process through activation of the aryl hydrocarbon receptor and subsequent mitochondrial reactive oxygen species production, which is known to activate transient receptor potential ankyrin-1 on nociceptive C-fibers.
Conclusions |
This study provides the first mechanistic insights into how exposure to urban air pollution leads to activation of guinea pig and human sensory nerves, which are responsible for respiratory symptoms. Mechanistic information will enable the development of appropriate therapeutic interventions and mitigation strategies for those susceptible subjects who are most at risk.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Key words : Pollution, oxidative stress, transient receptor potential ion channels, sensory nerves, vagus
Abbreviations used : AhR, DCM, DEP, DLS, DMSO, EDX, IIAM, MitoTEMPO, NAC, NIST, PAH, PM, PT, RAR, ROS, TEM, TGA, TRP, TRPA1, TTX, WT
Plan
R.K.R. was funded by a BBSRC Doctoral Training Programme. S.A.M. and E.D.B. were funded by a Medical Research Council (MRC, UK) MICA award (MR/K020293/1). S.J.B. was supported by a National Heart & Lung Institute (NHLI) studentship. M.A.W. was funded by the North West Lung Centre Charity. The human vagus experiments in this study were undertaken with the support of the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust. |
|
Disclosure of potential conflict of interest: R. K. Robinson receives grant support from the BBSRC. M. A. Birrell receives grant support from the Medical Research Council and NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and serves as a consultant for MedImmune and Imperial Spin-out Company IR Pharma. M. A. Wortley receives grant support from the North West Lung Centre Charity. S. Hu receives grant support from National Institute of Environmental Health Sciences (NIEHS). T. D. Tetley receives grant support from Biotechnology and Biological Sciences Research Council (BBSRC), Natural Environmental Research Council (NERC), National Institute for Environmental Health Science (US), and Public Health England. M. G. Belvisi receives grant support from BBSRC Doctoral Training Programmme, Medical Research Council UK, National Heart & Lung Institute (NHLI) studentship, North West Lung Centre Charity, Heptaras, Chiesi, AstraZeneca, Boehringer, Aboca, Ario, and NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and serves as a consultant for Aboca, Boehringer Ingelheim, Patara, Chiesi, Ario, NeRRe, MedImmune, Genetech, Blade, and Imperial Spin-out Company IR Pharma. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 141 - N° 3
P. 1074 - mars 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?